Last updated: 2026-09-16 14:41:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Twist Bioscience Corporation (TWST) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $144.82, with a market capitalisation of $8.93B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $23.30 to $155.44. This page covers its latest market performance, valuation, price trends and company information.
$8.93B | |
$142.28 | |
$214.07 | |
$11.46 | |
$138.10 | |
542.19K | |
1.72M | |
-- | |
$155.44 | |
$23.30 | |
-- | |
-- |
Twist Bioscience Corporation (TWST) is currently trading at $144.82 as of 2026-09-16 14:39:00, up 4.87% ($6.72) from the previous close of $138.10
During today's regular trading session, TWST has traded between $11.46 and $214.07, with a trading volume of 542.19K shares. The current price is near the middle of today's range.
Over the past seven days, Twist Bioscience Corporation (TWST) moved from $124.72 to $144.82, representing a gain of 16.12% ($20.10).
The stock traded between $120.19 and $148.23 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.43 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 92.0%
TWST is currently trading at $144.82, placing it 92.0% of the way from its 52-week low of $23.30 to its 52-week high of $155.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 979 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Twist Bioscience Corporation (TWST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.